Figure 5.
Correlation between plasma ARA content and ARA metabolites in blood and urine. (A) Urinary 11-dehydro TXB2, (B) urinary 2,3-dinor-6-keto- PGF1α, (C) urinary tetranor-PGEM, (D) plasma PGE2 and (E) plasma LXA4 after 4-week supplementation. Placebo, low-ARA and high-ARA groups are shown as crosses (n = 20), open circles, (n = 22) and closed squares (n = 22). No correlations were identified in any of these analyses (A)-(E).